bf/NYSE:CRL_icon.jpeg

COM:CRIVER

Charles River Laboratories International, Inc.

  • Stock

USD

Last Close

194.19

22/11 21:00

Market Cap

10.44B

Beta: -

Volume Today

575.72K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
88.93M
-
89.22M
0.32%
91.39M
2.43%
94.78M
3.71%
105.39M
11.19%
121.42M
15.21%
144.28M
18.82%
173.18M
20.03%
192.42M
11.11%
227.48M
18.22%
318.03M
39.81%
average payables
31.49M
-
32.79M
4.12%
35.24M
7.48%
52.58M
49.18%
73.16M
39.14%
72.04M
1.53%
88.87M
23.36%
116.99M
31.63%
160.30M
37.03%
202.02M
26.03%
187.43M
7.23%
average receivables
211.82M
-
239.31M
12.98%
264.03M
10.33%
317.06M
20.08%
397.03M
25.22%
451.13M
13.63%
493.14M
9.31%
565.89M
14.75%
630.31M
11.38%
697.64M
10.68%
766.38M
9.85%
book value per share
13.43
-
14.42
7.37%
15.77
9.36%
17.80
12.89%
22.01
23.67%
27.47
24.83%
33.54
22.09%
42.68
27.23%
50.40
18.10%
58.57
16.22%
69.91
19.35%
capex per share
-0.82
-
-1.22
48.86%
-1.36
11.43%
-1.18
13.55%
-1.74
47.63%
-2.92
68.25%
-2.88
1.28%
-3.36
16.57%
-4.55
35.32%
-6.39
40.50%
-6.19
3.13%
capex to depreciation
-0.41
-
-0.59
45.68%
-0.67
12.95%
-0.44
34.52%
-0.63
43.98%
-0.87
37.75%
-0.71
18.06%
-0.71
0.05%
-0.86
21.51%
-1.07
24.04%
-1.01
5.11%
capex to operating cash flow
-0.19
-
-0.23
19.96%
-0.22
2.59%
-0.19
16.10%
-0.26
40.63%
-0.32
21.81%
-0.29
7.97%
-0.30
4.30%
-0.30
1.32%
-0.52
74.28%
-0.47
11.13%
capex to revenue
-0.03
-
-0.04
30.58%
-0.05
5.76%
-0.03
29.13%
-0.04
34.95%
-0.06
39.28%
-0.05
13.26%
-0.06
6.26%
-0.06
13.44%
-0.08
26.38%
-0.08
5.55%
cash per share
3.50
-
3.78
7.97%
2.98
21.19%
2.58
13.29%
4.05
56.83%
4.09
1.11%
4.90
19.76%
4.63
5.57%
4.82
4.03%
4.60
4.44%
5.38
16.85%
days of inventory on hand
42.34
-
39.39
6.96%
41.11
4.36%
33.80
17.77%
36.32
7.44%
32.73
9.87%
35.26
7.73%
36.63
3.87%
32.96
10.02%
37.15
12.72%
52.84
42.23%
days payables outstanding
15.05
-
14.96
0.58%
16.09
7.52%
24.16
50.18%
24.59
1.80%
16.96
31.05%
24.47
44.32%
24.16
1.28%
32.79
35.72%
29.90
8.80%
23.47
21.50%
days sales outstanding
69.09
-
72.57
5.03%
72.31
0.36%
79.03
9.30%
84.49
6.92%
76.06
9.98%
71.58
5.90%
77.11
7.73%
66.28
14.05%
69.07
4.20%
68.98
0.13%
debt to assets
0.40
-
0.41
2.23%
0.42
1.12%
0.46
9.15%
0.39
14.18%
0.43
10.68%
0.43
1.26%
0.39
8.95%
0.42
6.87%
0.41
1.98%
0.43
5.06%
debt to equity
1.04
-
1.16
11.74%
1.18
1.74%
1.48
25.37%
1.10
25.76%
1.27
15.56%
1.23
3.15%
1.01
17.65%
1.15
14.05%
1.04
9.64%
0.98
6.29%
dividend yield
0.00
-
earnings yield
0.04
-
0.04
4.65%
0.04
5.12%
0.04
7.74%
0.02
45.06%
0.04
78.04%
0.03
19.45%
0.03
14.19%
0.02
27.91%
0.04
108.56%
0.04
11.14%
enterprise value
3.05B
-
3.62B
18.39%
4.47B
23.59%
4.70B
5.17%
6.18B
31.47%
6.83B
10.54%
9.17B
34.28%
14.38B
56.81%
21.25B
47.76%
13.94B
34.41%
14.95B
7.30%
enterprise value over ebitda
18.05
-
17.76
1.62%
19.37
9.10%
16.08
17.01%
16.78
4.40%
16.65
0.83%
16.29
2.16%
18.71
14.89%
25.91
38.45%
14.13
45.45%
14.49
2.52%
ev to operating cash flow
14.74
-
14.40
2.32%
15.60
8.35%
15.75
0.95%
19.53
24.01%
15.48
20.75%
19.07
23.17%
26.31
37.98%
27.93
6.15%
22.49
19.47%
21.86
2.78%
ev to sales
2.62
-
2.79
6.34%
3.28
17.64%
2.79
14.73%
3.33
19.00%
3.01
9.39%
3.50
16.08%
4.92
40.57%
6.00
22.04%
3.50
41.60%
3.62
3.32%
free cash flow per share
3.52
-
4.16
18.32%
4.80
15.25%
5.17
7.73%
4.92
4.73%
6.28
27.51%
6.99
11.25%
7.67
9.78%
10.58
37.93%
5.80
45.14%
7.10
22.35%
free cash flow yield
0.07
-
0.06
1.85%
0.06
7.47%
0.07
13.23%
0.04
33.68%
0.06
24.92%
0.05
18.20%
0.03
33.74%
0.03
5.96%
0.03
7.04%
0.03
12.78%
graham net net
-12.62
-
-16.44
30.24%
-19.68
19.69%
-30.11
53.00%
-27.25
9.52%
-39.69
45.68%
-47.64
20.02%
-51.70
8.51%
-71.75
38.78%
-71.90
0.21%
-67.71
5.82%
graham number
25.51
-
29.69
16.39%
33.75
13.69%
36.31
7.57%
35.87
1.21%
54.02
50.61%
62.48
15.64%
84.02
34.49%
93.89
11.75%
112.30
19.60%
120.46
7.26%
income quality
1.96
-
1.93
1.66%
1.88
2.53%
1.91
1.47%
2.52
31.76%
1.94
22.91%
1.89
2.50%
1.50
20.96%
1.91
27.49%
1.26
34.06%
1.42
13.18%
intangibles to total assets
0.19
-
0.27
38.36%
0.35
31.18%
0.44
25.28%
0.40
8.02%
0.48
20.19%
0.48
1.39%
0.47
0.48%
0.54
13.58%
0.50
6.82%
0.48
3.47%
interest coverage
7.22
-
14.87
105.92%
13.70
7.87%
8.57
37.45%
9.66
12.68%
5.20
46.18%
5.77
11.00%
5.01
13.20%
7.98
59.41%
10.98
37.57%
4.52
58.88%
interest debt per share
14.34
-
16.94
18.10%
18.89
11.49%
26.86
42.22%
24.74
7.87%
36.12
45.97%
42.38
17.34%
44.84
5.80%
59.52
32.73%
62.12
4.38%
70.83
14.01%
inventory turnover
8.62
-
9.27
7.48%
8.88
4.18%
10.80
21.62%
10.05
6.93%
11.15
10.95%
10.35
7.17%
9.96
3.73%
11.07
11.14%
9.83
11.28%
6.91
29.69%
invested capital
1.04
-
1.16
11.74%
1.18
1.74%
1.48
25.37%
1.10
25.76%
1.27
15.56%
1.23
3.15%
1.01
17.65%
1.15
14.05%
1.04
9.64%
0.98
6.29%
market cap
2.55B
-
3.00B
17.74%
3.72B
24.21%
3.58B
3.80%
5.20B
45.08%
5.36B
3.08%
7.40B
38.21%
12.47B
68.46%
18.57B
48.88%
11.07B
40.37%
12.16B
9.85%
net current asset value
-427.41M
-
-573.95M
34.28%
-743.70M
29.58%
-1.20B
61.51%
-1.04B
13.48%
-1.62B
55.85%
-2.00B
23.78%
-2.15B
7.03%
-3.16B
47.16%
-3.14B
0.57%
-2.93B
6.78%
net debt to ebitda
3.00
-
3.03
1.09%
3.23
6.45%
3.82
18.34%
2.67
30.26%
3.59
34.63%
3.14
12.59%
2.48
20.90%
3.27
31.59%
2.90
11.08%
2.70
6.92%
net income per share
2.15
-
2.72
26.15%
3.21
18.18%
3.29
2.51%
2.60
21.08%
4.72
81.73%
5.17
9.54%
7.35
42.16%
7.77
5.74%
9.57
23.09%
9.22
3.60%
operating cash flow per share
4.34
-
5.38
24.09%
6.16
14.39%
6.35
3.03%
6.66
4.97%
9.20
38.13%
9.87
7.27%
11.03
11.77%
15.13
37.14%
12.19
19.39%
13.29
9.00%
payables turnover
24.26
-
24.40
0.58%
22.69
6.99%
15.11
33.41%
14.84
1.77%
21.52
45.03%
14.91
30.71%
15.11
1.30%
11.13
26.32%
12.21
9.65%
15.55
27.39%
receivables turnover
5.28
-
5.03
4.79%
5.05
0.36%
4.62
8.50%
4.32
6.47%
4.80
11.08%
5.10
6.27%
4.73
7.18%
5.51
16.34%
5.28
4.03%
5.29
0.13%
research and ddevelopement to revenue
return on tangible assets
0.08
-
0.09
18.25%
0.11
21.03%
0.10
8.61%
0.07
30.53%
0.11
61.23%
0.10
9.69%
0.13
23.01%
0.12
4.47%
0.13
6.47%
0.11
12.49%
revenue per share
24.41
-
27.83
13.99%
29.32
5.35%
35.76
21.98%
39.12
9.39%
47.26
20.80%
53.79
13.81%
59.01
9.70%
70.39
19.29%
78.25
11.17%
80.26
2.57%
roe
0.16
-
0.19
17.49%
0.20
8.06%
0.18
9.19%
0.12
36.18%
0.17
45.59%
0.15
10.28%
0.17
11.74%
0.15
10.47%
0.16
5.91%
0.13
19.23%
roic
0.09
-
0.09
1.37%
0.10
12.26%
0.08
20.26%
0.06
30.81%
0.09
61.29%
0.08
12.75%
0.08
2.72%
0.09
6.85%
0.08
7.13%
0.07
14.87%
sales general and administrative to revenue
shareholders equity per share
13.43
-
14.42
7.37%
15.77
9.36%
17.80
12.89%
22.01
23.67%
27.47
24.83%
33.54
22.09%
42.68
27.23%
50.40
18.10%
58.57
16.22%
69.91
19.35%
stock based compensation to revenue
0.02
-
0.02
13.58%
0.03
23.06%
0.03
11.81%
0.02
8.73%
0.02
11.80%
0.02
4.57%
0.02
11.81%
0.02
4.78%
0.02
8.29%
0.02
5.77%
tangible asset value
349.42M
-
204.39M
41.50%
45.93M
77.53%
-328.18M
814.51%
-110.65M
66.28%
-519.72M
369.69%
-563.50M
8.42%
-453.10M
19.59%
-1.18B
160.67%
-781.67M
33.82%
-300.10M
61.61%
tangible book value per share
7.32
-
4.38
40.11%
0.99
77.46%
-6.98
806.64%
-2.33
66.61%
-10.84
365.12%
-11.56
6.68%
-9.14
20.92%
-23.48
156.82%
-15.38
34.49%
-5.83
62.09%
working capital
305.52M
-
310.73M
1.71%
247.47M
20.36%
227.24M
8.18%
363.12M
59.80%
339.61M
6.47%
311.14M
8.38%
361.38M
16.15%
240.91M
33.34%
347.45M
44.22%
553.58M
59.33%

All numbers in USD (except ratios and percentages)